ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,490, issued on Aug. 19, was assigned to MUSC FOUNDATION FOR RESEARCH DEVELOPMENT.

"Sphingolipid-based selenium compounds, methods for their preparation, and pharmaceutical uses thereof, including as antitumor agents" was invented by Zdzislaw M. Szulc (Charleston, S.C.), Besim Ogretmen (Mount Pleasant, S.C.) and Natalia Oleinik (Charleston, S.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Ionic conjugates of selenite anions and cationic ceramide analogs are described. For instance, conjugates can comprise ionic conjugates of selenite anions and pyridimin-substituted ceramide analogs. Also described is the use of the ionic conjugates in treating ca...